{{Rsnum
|rsid=162555
|Chromosome=2
|position=38080367
|Orientation=minus
|GMAF=0.1217
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 64.6 | 30.1 | 5.3
| HCB | 94.9 | 5.1 | 0.0
| JPT | 94.7 | 5.3 | 0.0
| YRI | 72.1 | 23.1 | 4.8
| ASW | 80.7 | 19.3 | 0.0
| CHB | 94.9 | 5.1 | 0.0
| CHD | 91.7 | 8.3 | 0.0
| GIH | 77.2 | 20.8 | 2.0
| LWK | 62.7 | 37.3 | 0.0
| MEX | 70.7 | 27.6 | 1.7
| MKK | 67.3 | 30.1 | 2.6
| TSI | 61.8 | 36.3 | 2.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19630952
|Title=Sex steroid metabolism polymorphisms and mammographic density in pre- and early peri-menopausal women
|OA=1
}}

{{PMID Auto
|PMID=16949388
|Title=CYP1A1 and CYP1B1 polymorphisms and their association with estradiol and estrogen metabolites in women who are premenopausal and perimenopausal.
}}

{{PMID Auto
|PMID=18632753
|Title=Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | Illumina Human 1M}}